{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:39:59Z","timestamp":1773416399475,"version":"3.50.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Yunnan Fundamental Research Projects","award":["202501AU070063"],"award-info":[{"award-number":["202501AU070063"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,25]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Ankylosing spondylitis (AS) is a chronic inflammatory disease that typically affects the axial skeleton. Renal involvement is rare in AS, only occurring in 5\u201313% of AS patients. Membranous nephropathy (MN) in patients with AS is extremely rare. There have been only a few cases showing the association between MN and AS. Herein we report a case of AS-associated MN in a 47-year-old male. He was diagnosed with AS-associated MN after renal biopsy, and he was treated with corticosteroids and cyclophosphamide. His low back pain and oedema disappeared gradually and serum albumin and urine protein excretion significantly improved after treatment. In clinical practice, AS patients with proteinuria or renal dysfunction should be evaluated for MN through \u200cserum anti-phospholipase A2 receptor autoantibody (anti-PLA2R antibody) testing\u200c and \u200crenal biopsy\u200c to confirm diagnosis.<\/jats:p>","DOI":"10.1093\/mrcr\/rxaf049","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:33:23Z","timestamp":1753878803000},"source":"Crossref","is-referenced-by-count":1,"title":["Membranous nephropathy in ankylosing spondylitis: a rare case report"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5590-9022","authenticated-orcid":false,"given":"Yin","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Nephrology and Rheumatology, The Affiliated Hospital of Yunnan University, The Second People's Hospital of Yunnan Province , Kunming, Yunnan ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, The Affiliated Hospital of Yunnan University, The Second People's Hospital of Yunnan Province , Kunming, Yunnan ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, The Affiliated Hospital of Yunnan University, The Second People's Hospital of Yunnan Province , Kunming, Yunnan ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhua","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, The Affiliated Hospital of Yunnan University, The Second People's Hospital of Yunnan Province , Kunming, Yunnan ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaoyang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, The Affiliated Hospital of Yunnan University, The Second People's Hospital of Yunnan Province , Kunming, Yunnan ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongfeng","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, The Affiliated Hospital of Yunnan University, The Second People's Hospital of Yunnan Province , Kunming, Yunnan ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"2025082009020019700_ref1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s0140-6736(16)31591-4","article-title":"Axial spondyloarthritis","volume":"390","author":"Sieper","year":"2017","journal-title":"Lancet"},{"key":"2025082009020019700_ref2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/rheumatology\/key128","article-title":"Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis","volume":"58","author":"Heijde","year":"2019","journal-title":"Rheumatology (Oxford, England)"},{"key":"2025082009020019700_ref3","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13075-016-1093-z","article-title":"Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis","volume":"18","author":"Winter","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2025082009020019700_ref4","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s00296-012-2624-9","article-title":"Renal involvement in ankylosing spondylitis: prevalence, pathology, response to TNF-a blocker","volume":"33","author":"Lee","year":"2013","journal-title":"Rheumatol Int"},{"key":"2025082009020019700_ref5","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/bf01451293","article-title":"Renal diseases in ankylosing spondylitis: review of the literature illustrated by case reports","volume":"17","author":"Strobel","year":"1998","journal-title":"Clin Rheumatol"},{"key":"2025082009020019700_ref6","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/acr.22176","article-title":"Estimating the occurrence of renal complications among persons with ankylosing spondylitis","volume":"66","author":"Levy","year":"2014","journal-title":"Arthritis Care Res"},{"key":"2025082009020019700_ref7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1590\/2175-8239-jbn-2022-0008","article-title":"Kidney disease in ankylosing spondylitis: a case series and review of the literature","volume":"45","author":"Rodrigues","year":"2023","journal-title":"J Brasil Nefrol"},{"key":"2025082009020019700_ref8","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1159\/000509248","article-title":"Spectrums and prognosis of kidney disease in patients with ankylosing spondylitis","volume":"6","author":"He","year":"2020","journal-title":"Kidney Dis (Basel)"},{"key":"2025082009020019700_ref9","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.kint.2019.07.014","article-title":"The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery","volume":"96","author":"Logt","year":"2019","journal-title":"Kidney Int"},{"key":"2025082009020019700_ref10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00441-021-03429-4","article-title":"Perspectives in membranous nephropathy","volume":"385","author":"Tomas","year":"2021","journal-title":"Cell Tissue Res"},{"key":"2025082009020019700_ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00303-z","article-title":"Membranous nephropathy","volume":"7","author":"Ronco","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2025082009020019700_ref12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.5606\/tftrd.2023.8801","article-title":"Membranous nephropathy in a patient with ankylosing spondylitis: a rare renal manifestation or just a coincidence?","volume":"69","author":"K\u00f6seo\u011flu Tohma","year":"2023","journal-title":"Turk J Physical Med Rehabil"},{"key":"2025082009020019700_ref13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.kint.2023.04.006","article-title":"Proprotein convertase subtilisin\/kexin type 6 (PCSK6) is a likely antigenic target in membranous nephropathy and nonsteroidal anti-inflammatory drug use","volume":"104","author":"Sethi","year":"2023","journal-title":"Kidney Int"},{"key":"2025082009020019700_ref14","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1053\/j.ajkd.2013.03.045","article-title":"Membranous nephropathy and nonsteroidal anti-inflammatory agents","volume":"62","author":"Nawaz","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"2025082009020019700_ref15","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1042\/cs20181110","article-title":"Lipid metabolism participates in human membranous nephropathy identified by whole-genome gene expression profiling","volume":"133","author":"Wu","year":"2019","journal-title":"Clin Sci"},{"key":"2025082009020019700_ref16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2215\/cjn.0000000000000098","article-title":"Worsened outcome in patients with membranous nephropathy carrying apolipoprotein L1 high-risk genotype","volume":"18","author":"Susztak","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025082009020019700_ref17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","article-title":"Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease","volume":"19","author":"Mitrofanova","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"2025082009020019700_ref18","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/ndt\/gfg616","article-title":"Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy","volume":"19","author":"Ohtani","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"2025082009020019700_ref19","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1093\/ckj\/sfad209","article-title":"Causal effects of rheumatoid arthritis or ankylosing spondylitis on membranous nephropathy: a two-sample Mendelian randomization study","volume":"16","author":"Wang","year":"2023","journal-title":"Clin Kidney J"},{"key":"2025082009020019700_ref20","doi-asserted-by":"publisher","first-page":"e15023","DOI":"10.1111\/1756-185x.15023","article-title":"Genetic risk factors in ankylosing spondylitis: insights into etiology and disease pathogenesis","volume":"27","author":"Mathew","year":"2024","journal-title":"Int J Rheum Dis"},{"key":"2025082009020019700_ref21","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1007\/s10753-024-01992-w","article-title":"IL-23\/IL-17 in a paradoxical association with primary membranous nephropathy","volume":"47","author":"Kaur","year":"2024","journal-title":"Inflammation"},{"key":"2025082009020019700_ref22","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaf030","article-title":"T cell costimulatory blockade ameliorates induction of experimental membranous nephropathy potentially through T-helper 17 cell suppression in the kidney","author":"Chung","year":"2025;030.","journal-title":"Nephrol Dial Transplant"},{"key":"2025082009020019700_ref23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41584-021-00625-y","article-title":"Ankylosing spondylitis: an autoimmune or autoinflammatory disease?","volume":"17","author":"Mauro","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"2025082009020019700_ref24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update","volume":"82","author":"Ramiro","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025082009020019700_ref25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3109\/03009748609092589","article-title":"A trial of cyclophosphamide in ankylosing spondylitis with involvement of peripheral joints and high disease activity","volume":"15","author":"Sadowska-Wr\u00f3blewska","year":"1986","journal-title":"Scand J Rheumatol"},{"key":"2025082009020019700_ref26","doi-asserted-by":"publisher","first-page":"e8201","DOI":"10.1097\/md.0000000000008201","article-title":"Membranous nephropathy in a patient with ankylosing spondylitis: a case report","volume":"96","author":"Chen","year":"2017","journal-title":"Medicine"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxaf049\/63891470\/rxaf049.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/9\/2\/rxaf049\/63891470\/rxaf049.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/9\/2\/rxaf049\/63891470\/rxaf049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T13:03:04Z","timestamp":1755694984000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/doi\/10.1093\/mrcr\/rxaf049\/8219024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,7,25]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxaf049","relation":{},"ISSN":["2472-5625"],"issn-type":[{"value":"2472-5625","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"rxaf049"}}